<![CDATA[Telitacicept Moves Forward in Global Phase 3 Study for Generalized Myasthenia Gravis]]>
Post Content: Source: Neurology Read More
<![CDATA[Once-Daily Alixorexton Improves Cognition, Fatigue, and Disease Severity in Phase 2 Narcolepsy Type 1 Study]]>
Post Content: Source: Neurology Read More
<![CDATA[NMOSD Associated With Escalation to Rituximab, Elecsys NfL Test Receives European Approval, Neurology by the Numbers]]>
Post Content: Source: Neurology Read More
<![CDATA[GLP-1 Receptor Agonists Show Translational Potential in Alzheimer Disease Despite Mixed Study Results]]>
<![CDATA[Using VISIBL-MS to Improve Early Detection and Diagnostic Pathways in Multiple Sclerosis]]>
What APA Is Doing for You: Update on Clozapine REMS
In November 2021, the Food and Drug Administration (FDA) instituted a new Clozapine Risk Evaluation and Mitigation Strategy (REMS) to…
Read More
